| Literature DB >> 23448802 |
A C Ng1, D C Wai, E S Tai, K M Ng, L L Chan.
Abstract
OBJECTIVES: Visceral adipose tissue (VAT) is an independent risk factor in cardiometabolic diseases and is commonly measured by computed tomography (CT). It is measured clinically by waist circumference (WC). The L4/5 intervertebral space VAT (L4/5 VAT) is traditionally used to represent total VAT volume. We set out to determine (1) the level of intervertebral space on CT that best approximates the total VAT volume; (2) compare the association between WC and VAT in Singaporean Chinese and Indian; and (3) examine the correlation between VAT and cardiometabolic risk factors.Entities:
Year: 2012 PMID: 23448802 PMCID: PMC3432182 DOI: 10.1038/nutd.2012.12
Source DB: PubMed Journal: Nutr Diabetes ISSN: 2044-4052 Impact factor: 5.097
Baseline characteristics—mean (s.d.); n (%)
| Age | 66.8 (4.7) | 65.7 (7.0) |
| Weight (kg) | 65.3 (14.5) | 70.0 (13.5) |
| Height (cm) | 164 (6) | 165 (7) |
| BMI | 24.1 (4.3) | 26.3 (4.3) |
| Waist circumference (cm) | 84.7 (9.5) | 88.5 (14.1) |
| Hip circumference (cm) | 89.1 (17.0) | 92.7 (13.6) |
| Waist–hip ratio | 0.964 (0.105) | 0.958 (0.094) |
| L23 level VAT (mm3) | 78 213 (36 599) | 88 771 (41 980) |
| Systolic BP (mm Hg) | 136 (20) | 134 (22) |
| Diastolic BP (mm Hg) | 79 (9.8) | 76 (12) |
| Resistin (ng ml−1) | 10.2 (5.82) | 7.79 (2.83) |
| Leptin (μg l−1) | 4.51 (2.65) | 8.88 (6.13) |
| Adiponectin (ng ml−1) | 5999 (2992) | 6465 (3755) |
| Hs-CRP (mg l−1) | 1.48 (1.74) | 2.88 (3.32) |
| Fasting glucose (mmol l−1) | 5.43 (0.89) | 6.57 (2.54) |
| Fasting insulin (μU ml−1) | 6.87 (6.22) | 8.40 (4.45) |
| HOMA-IR | 1.69 (1.72) | 2.61 (2.27) |
| Total cholesterol (mmol l−1) | 5.39 (0.76) | 4.87 (0.99) |
| HDL-cholesterol (mmol l−1) | 1.26 (0.27) | 1.10 (0.22) |
| Triglyceride (mmol l−1) | 1.51 (0.85) | 1.38 (0.72) |
| LDL-cholesterol (mmol l−1) | 3.45 (0.88) | 3.13 (0.88) |
| Hypertension on medication | 0 (0%) | 37 (62%) |
| Diabetes on medication | 0 (0%) | 19 (32%) |
| Hyperlipidemia on medication | 0 (0%) | 20 (33%) |
Abbreviations: BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment-insulin resistance; LDL, low-density lipoprotein; VAT, visceral adipose tissue.
Chinese and Asian Indian between group difference significant at P<0.05.
The values presented in the above table represent mean (s.d.), except for the proportion of patients with hypertension, diabetes and hyperlipidemia on medications, for which the values represent n (%).
R 2 for correlation between VAT area and total VAT volume Chinese and Asian Indian
| R | ||
|---|---|---|
| T11/12 | 0.886 | 0.682 |
| T12/L1 | 0.838 | 0.854 |
| L1/L2 | 0.967 | 0.942 |
| L2/L3 | 0.974 | 0.946 |
| L3/L4 | 0.952 | 0.944 |
| L4/L5 | 0.874 | 0.641 |
| L5/S1 | 0.785 | 0.563 |
Abbreviation: VAT, visceral adipose tissue.
Figure 1Correlation between WC and VAT at L2/3 intervertebral space by racial groups.
Figure 2Correlation between WC and IP-AT by racial groups.
Figure 3Correlation between WC and RP-AT by racial groups.
Linear regression beta and P-values between clinical and biochemical parameters and L23 VAT, L45 VAT and waist, with or without adjustment for BMI
| Adjusted systolic BP | 0.179, 0.054 | 0.091, 0.442 | 0.074, 0.431 | −0.058, 0.954 | 0.131, 0.161 | 0.041, 0.383 | 0.202, 0.033 |
| Adjusted diastolic BP | 0.163, 0.067 | 0.086, 0.448 | 0.012, 0.859 | −0.070, 0.471 | 0.133, 0.138 | 0.057, 0557 | 0.181, 0.046 |
| Ln (fasting glucose) | 0.420, <0.001 | 0.420, <0.001 | 0.185, 0.065 | 0.087, 0.424 | 0.405, <0.001 | 0.370, 0.001 | 0.265, 0.008 |
| Ln (fasting insulin) | 0.469, <0.001 | 0.391, 0.001 | 0.197, 0.050 | 0.044, 0.676 | 0.397, <0.001 | 0.279, 0.012 | 0.373, <0.001 |
| Ln (HOMA-IR) | 0.521, <0.001 | 0.451, <0.001 | 0.221, 0.027 | 0.060, 0.559 | 0.453, <0.001 | 0.339, 0.002 | 0.398, <0.001 |
| HDL-c | −0.250, 0.008 | −0.234, 0.045 | −0.173, 0.073 | −0.126, 0.235 | −0.250, 0.009 | −0.223, 0.041 | −0.167, 0.087 |
| Ln (TG) | 0.219, 0.030 | 0.342, 0.006 | 0.225, 0.027 | 0.279, 0.013 | 0.208, 0.040 | 0.283, 0.015 | −0.011, 0.916 |
| Ln (leptin) | 0.425, <0.001 | 0.241, 0.008 | 0.220, 0.008 | 0.054, 0.495 | 0.419, <0.001 | 0.261, 0.002 | 0.456, <0.001 |
| Ln (adiponectin) | −0.343, <0.001 | −0.288, 0.011 | −0.181, 0.054 | −0.091, 0.359 | −0.272, 0.003 | −0.185, 0.076 | −0.272, 0.004 |
| Ln (hs-CRP) | 0.259, 0.003 | 0.180, 0.106 | 0.073, 0.418 | −0.027, 0.781 | 0.210, 0.018 | 0.119, 0.240 | 0.244, 0.007 |
Abbreviations: BP, blood pressure; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment-insulin resistance; Hs-CRP, highly sensitive C-reactive protein; TG, triglyceride; VAT, visceral adipose tissue.
Model 1: adjusted for age and race; Model 2: adjusted for age, race and BMI.
Linear regression beta and P-values between clinical and biochemical parameters and IP-AT, RP-AT at L2/3, with or without adjustment for BMI
| Adjusted systolic BP | 0.202, 0.032 | 0.125, 0.297 | 0.102, 0.276 | 0.007, 0.949 |
| Adjusted diastolic BP | 0.155, 0.087 | 0.070, 0.543 | 0.148, 0.098 | 0.080, 0.430 |
| Ln (fasting glucose) | 0.471, <0.001 | 0.490, <0.001 | 0.278, 0.005 | 0.192, 0.100 |
| Ln (fasting insulin) | 0.413, <0.001 | 0.296, 0.012 | 0.514, <0.001 | 0.447, <0.001 |
| Ln (HOMA-IR) | 0.484, <0.001 | 0.383, 0.001 | 0.527, <0.001 | 0.446, <0.001 |
| HDL-c | −0.261, 0.007 | −0.243, 0.038 | −0.196, 0.040 | −0.152, 0.171 |
| Ln (TG) | 0.243, 0.018 | 0.363, 0.003 | 0.144, 0.156 | 0.203, 0.086 |
| Ln (leptin) | 0.410, <0.001 | 0.208, 0.026 | 0.375, <0.001 | 0.207, 0.012 |
| Ln (adiponectin) | −0.333, <0.001 | −0.267, 0.022 | −0.294, <0.001 | −0.215, 0.037 |
| Ln (hs-CRP) | 0.259, 0.004 | 0.175, 0.123 | 0.213, 0.017 | 0.126, 0.210 |
Abbreviations: BP, blood pressure; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment-insulin resistance; Hs-CRP, highly sensitive C-reactive protein; IP-AT, intraperitoneal adipose tissue; RP-AT, retroperitoneal adipose tissue; TG, triglyceride.
Model 1: adjusted for age and race; Model 2: adjusted for age, race and BMI.